Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases

Background: Cardiometabolic morbidity and medications, specifically Angiotensin Converting Enzyme inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs), have been linked with adverse outcomes from coronavirus disease 2019 (COVID-19). This study aims to investigate, factors associated with COVID...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Cardiovasc Med
Hlavní autoři: Raisi-Estabragh, Zahra, McCracken, Celeste, Ardissino, Maddalena, Bethell, Mae S., Cooper, Jackie, Cooper, Cyrus, Harvey, Nicholas C., Petersen, Steffen E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Cardiovascular Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7381180/
https://ncbi.nlm.nih.gov/pubmed/32766285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2020.00138
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky